Truini, Anna
Germano, Giovanni
Bardelli, Alberto
Funding for this research was provided by:
Seventh Framework Programme (635342-2 MoTriColor)
Seventh Framework Programme (602901 MErCuRIC)
Seventh Framework Programme (115749 CANCER-ID)
Article History
Received: 8 October 2018
Accepted: 20 November 2018
First Online: 28 November 2018
Competing interests
: AB is a shareholder of Phoremost. AB and GG are co-founders and shareholders of Neophore Limited. The remaining author declares that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.